“…Interestingly, only the α-secretase inhibitor TAPI-2 (Enzo LifeSciences, Lörrach, Germany, 20 μM final concentration) reduced CTF formation whereas the β-secretase inhibitor ( 10 μM final concentration; β-secretase inhibitor II, BioVision Research Products, California, USA) and γ-secretase inhibitor (III-31C, Sigma, 0.2 μM final concentration) had no effect (Fig. 3c) suggesting that endosomal APP procession is mediated mainly via the two possible α-secretases ADAM-10 and/or TACE (Jacobsen et al 2010). However, Western blot analysis of BACE-1, ADAM-10, and TACE did not show any differences between wild-type and siIRS-2 cells (Fig.…”